Investing.com - Semler Scientifc reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Semler Scientifc announced earnings per share of $0.550 on revenue of $14M. Analysts polled by Investing.com anticipated EPS of $0.320 on revenue of $14.92M.
Semler Scientifc shares are down 58% from the beginning of the year, still down 71.55% from its 52 week high of $151.15 set on November 1, 2021.
Semler Scientifc follows other major Healthcare sector earnings this month
Semler Scientifc's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar